All articles by
Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and characterization, today announced the initiation…
CardioSignal Raises $10m in Series A as the First Technology to Detect Major Heart Diseases without Specialised Medical Hardware
CardioSignal today announced the closing of $10m in Series A funding, led by DigiTx Partners, with participation from Sandwater and…
Pi-Cardia gets FDA breakthrough status for ShortCut leaflet modification device
Israeli medical device start-up Pi-Cardia has received breakthrough device designation from the US Food and Drug Administration (FDA) for its…
Single Pass, Mermaid Medical sign US distribution deal for biopsy closure device
Single Pass has signed an exclusive distribution agreement with Mermaid Medical Group to distribute the former’s biopsy closure device to…
Modular Medical seeks FDA 510(k) clearance for MODD1 insulin pump
US-based insulin delivery technology company Modular Medical has submitted its next-generation MODD1 insulin pump to the US Food and Drug…
Biovica signs distribution deal with Palex for DiviTum TKa test in Spain, Portugal
Cancer monitoring company Biovica has entered a collaboration agreement with the Palex Group to distribute DiviTum TKa cancer test in…
Tempus launches xM MRD assay for colorectal cancer patients
Tempus, a company focused on artificial intelligence and precision medicine, has launched xM assay to detect minimal residual disease (MRD)…
Orthofix signs distribution deal with MRIguidance for BoneMRI software in US
Spine and orthopaedics company Orthofix Medical has signed a commercial distribution agreement with Dutch firm MRIguidance for its BoneMRI imaging…
Kallisio Patient-tailored Oral Stent for Head and Neck Cancer Treatment Receives FDA Clearance
Kallisio, focused on developing solutions to manage toxicity in cancer care, announces FDA 510(k) clearance for Stentra, an individually tailored 3D…
ONWARD Announces Start of HemON NL Clinical Study
ONWARD Medical, the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people…